Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 1 February 2022
First Online: 28 March 2022
Compliance with Ethical Standards
:
: Jordan Senchak declares that he has no conflict of interest. Katya Ahr declares that she has no conflict of interest. Margaret von Mehren has received institutional research funding for clinical trials from Blueprint Medicines, Bayer, Novartis, Pfizer, and Deciphera; has served as a paid consultant to Blueprint Medicines, Deciphera, and Exelixis; and has served on the scientific steering committees for the NAVIGATOR trial (Blueprint Medicines) and INVICTUS and INTRIGUE trials (Deciphera).
